Cortelazzo, S., Finazzi, G., Ruggeri, M., Vestri, O., Galli, M., Rodeghiero, F., et al. (1995) Hydroxyurea for Patients with Essential Thrombocythemia and a High Risk of Thrombosis. The New England Journal of Medicine, 332, 1132-1136.
https://doi.org/10.1056/NEJM199504273321704

has been cited by the following article:

• TITLE: Essential Thrombocytosis and Fatal Coronary Graft Occlusion: A Case Report

  AUTHORS: Joseph L. Blidgen, Clarence D. McGaw

  KEYWORDS: Thrombocytosis, Graft Occlusion, Coronary Artery Bypass Grafting

  JOURNAL NAME: World Journal of Cardiovascular Surgery, Vol.10 No.10, October 26, 2020

  ABSTRACT: Essential thrombocytosis (ET) is a rare myeloproliferative disorder, which is a major risk factor for thrombosis and bleeding, which complicates cardiovascular surgery. ET is a risk factor for coronary artery disease that should be treated. We present a case of a male with ET who underwent coronary artery bypass grafting (CABG) at the University Hospital of the West Indies, and died post-surgery. Post mortem revealed early graft thrombosis. We believe that post-operative aspirin therapy maybe would have prevented this fatal outcome.